1. Australia
  2. All 3M Products
  3. Medical
  4. Skin Care
  5. No-Sting Barrier Films
  6. 3M™ Cavilon™ No Sting Barrier Film 1mL Wand 3343
This product is not available for purchase by the general public.
This product is now sponsored by KCI Medical Australia Pty Ltd. (Level 3, Building A, 1 Rivett Road, North Ryde, NSW 2113), wholly owned subsidiaries of Solventum.

3M™ Cavilon™ No Sting Barrier Film 1mL Wand 3343

  • 3M ID 70200770777

The intelligent choice to help prevent medical adhesive-related skin injury (MARSI) around infusion sites: CHG compatible³

Clinically proven, cost effective, long lasting protection from incontinence-associated dermatitis (IAD)¹'²

Will not clog or reduce absorbency of diapers or pads

View more details
Frequently viewed resources
PDF (1) Copy 26Safety Data Sheet (PDF)

Details

Highlights
  • The intelligent choice to help prevent medical adhesive-related skin injury (MARSI) around infusion sites: CHG compatible³
  • Clinically proven, cost effective, long lasting protection from incontinence-associated dermatitis (IAD)¹'²
  • Will not clog or reduce absorbency of diapers or pads
  • Protects intact or damaged skin
  • Sterile, non-cytotoxic³
  • Alcohol-free, sting-free
  • Hypoallergenic³
Take cover in proven protection. Cavilon No Sting Barrier Film is a unique terpolymer based, alcohol-free liquid barrier film that protects intact or damaged skin from bodily fluids, adhesive trauma, friction and incontinence. It is clinically proven, and trusted by clinicians to provide a high level of barrier protection of up to 72 hours from irritation due to incontinence.¹'² In fact, 3M has over 70 pieces of clinical evidence supporting the efficacy and cost-effectiveness of Cavilon No Sting Barrier Film in a wide range of clinical applications - substantially more evidence than any other moisture barrier or barrier film.³

Click here to learn more and to see what resources are available

It is designed to protect intact, damaged or 'at-risk' skin from urine, faeces, other body fluids, medical adhesive related skin injury (MARSI) and friction. It comes in a variety of easy to apply formats: 1ml foam applicator, 3ml foam applicator, 28ml pump spray and a stoma wipe. It lasts for up to 72 hours, and will not sting when applied to broken skin.

Suggested applications
  • Perineal skin protection from urine and faeces
  • Peri-stomal skin protection from adhesives, urine or faeces
  • Peri-wound protection from wound exudate
  • Peri-tube and device protection from drainage or bodily fluids
  • Skin protection from adhesives
  • Skin protection from friction
  • Management of skin during radiation therapy

Specifications

Boxes per Case

4.0

Brands

Cavilon™

Catalog Number

3343

Condition

I.V. Related, Wound Care, Dressing & Device Securement, Pressure Ulcer, Skin Care

Delivery System

Wand

Dressing and Device Securement Condition Type

Adhesive Trauma, Surgical Wound, Tube & Device Securement-Lightweight Tubes & Devices, Skin Injuries-Allergic & Irritant Contact Dermatitis, Skin Injuries-Maceration, Skin Injuries-Mechanical, Tube & Device Securement-Infusion & Monitoring

Hypoallergenic

Yes

IV Related Condition Type

CVC Dialysis, CVC PICC, Epidural Catheter, PIV, CVC Tunneled, Arterial Catheter, CVC Implanted Port, CVC Short-Term

Latex

No

Product Type

Barrier Film

Units per Case

100.0

Units per Pack

25

Volume (metric)

1 mL

Resources

1. Bliss DZ, Zehrer C, Savik K, Smith G, Hedblom E. An economic evaluation of four skin damage prevention regimens in nursing home residents with incontinence. J WOCN 2007; 34(2):143-52.

2. Bale S, Tebble N, Jones VJ, Price PE. The benefits of introducing a new skin care protocol in patients cared for in nursing homes. (2004) J Tissue Viability 14(2): 44 – 50.

3. 3M Data on File.

4. Hart J. Assessment of the incontinence pad blocking potential of 3M™ Cavilon™ Durable Barrier Cream compared with Sudocrem™ and Zinc and Castor Oil. Nursing Scotland 2002, Issue: July/August.,1. Bliss DZ, Zehrer C, Savik K, Smith G, Hedblom E. An economic evaluation of four skin damage prevention regimens in nursing home residents with incontinence. J WOCN 2007; 34(2):143-52.
2. Bale S, Tebble N, Jones VJ, Price PE. The benefits of introducing a new skin care protocol in patients cared for in nursing homes. (2004) J Tissue Viability 14(2): 44 – 50.
3. 3M data on file